What Are Lab Babies? The Facts on IVF and Conception

“Lab babies” is an informal term for children conceived through in vitro fertilization, a process where eggs and sperm are combined in a laboratory dish rather than inside the body. The phrase traces back to 1978, when the birth of Louise Brown in England made headlines as the world’s first “test-tube baby,” a label that stuck in the public imagination even though no test tubes are actually involved. Since then, IVF has produced an estimated twelve million children worldwide, and the technology has evolved dramatically from the single-egg, single-attempt procedure that created Brown into a complex medical specialty with multiple techniques, genetic screening options, and embryo storage capabilities.

How the Term Started and Why It Persists

Louise Brown’s birth in July 1978 marked the moment when technologically assisted human reproduction became real rather than theoretical.¹ The British media quickly coined “test-tube baby,” and international outlets ran with it. The phrase captured something true about the process: fertilization happens outside a woman’s body. But it also created a lasting misconception that babies somehow grow in laboratory glassware. In reality, a fertilized egg spends at most five or six days in a lab dish before being transferred back to a uterus, where it implants and develops like any other pregnancy. The term “lab baby” carries the same baggage. It is catchy, and it is misleading.

What Actually Happens During IVF

An IVF cycle unfolds in several distinct stages, each with its own medications, timing considerations, and decisions. Understanding the sequence helps explain why the process takes weeks, costs thousands of dollars, and why outcomes vary so much from one person to the next.

Ovarian Stimulation

In a natural menstrual cycle, your body matures one egg. IVF aims for more. Doctors prescribe hormone medications that push the ovaries to produce roughly five to ten mature eggs at once.² This stimulation phase typically lasts about ten to fourteen days and involves daily injections. Additional medications prevent the body from releasing those eggs prematurely. The whole protocol is carefully monitored with blood tests and ultrasounds, and it can be both physically uncomfortable and logistically demanding. Ovarian stimulation disrupts the normal physiology of egg development, with consequences that ripple into how the embryo forms and how the uterine lining responds.³

Fertilization in the Lab

Once eggs are retrieved through a minor surgical procedure, they meet sperm in one of two ways. In conventional IVF, thousands of sperm are placed in a dish with each egg, and fertilization happens on its own. In ICSI, a single sperm is injected directly into the egg using a microscopic needle. ICSI was originally developed for severe male-factor infertility, but it has become widely used even when sperm quality is normal. The two methods produce different results depending on the context. In cases without a male-factor issue, conventional IVF has shown higher fertilization and implantation rates in some studies,⁴ while other research using split insemination (half the eggs fertilized each way for the same patient) found ICSI oocytes had a higher fertilization rate per egg but conventional IVF embryos had better blastocyst development per fertilized egg.⁵ The choice between the two depends on the couple’s specific diagnosis and the clinic’s philosophy.

Embryo Culture and Transfer

Fertilized eggs develop in an incubator for three to six days. The lab mimics the conditions inside a fallopian tube as closely as possible, carefully controlling temperature, pH, gas concentrations, and even light exposure to prevent stress on the embryo.⁶ By day five or six, an embryo that has developed well reaches the blastocyst stage, a hollow ball of about 100 to 200 cells. At that point, one or more embryos are transferred to the uterus through a thin catheter. Any remaining good-quality embryos can be frozen for later use.

How Age Shapes IVF Success

No single factor matters more to IVF outcomes than the age of the person providing the eggs. A large UK study of over 150,000 women found that for those younger than 40 using their own eggs, the live-birth rate from a first cycle was about 32%, and the cumulative rate after six cycles reached roughly 65 to 80% depending on how the calculation handled dropouts.⁷ For women aged 40 to 42, the first-cycle rate dropped to about 12%, with six cycles yielding a cumulative rate in the range of 20 to 42%. For women over 42 using their own eggs, each cycle’s success rate fell below 4%.

Younger patients see similar patterns across different datasets. One analysis found cumulative live-birth rates approaching 70% after six cycles for patients under 35 and around 84% for those aged 36 to 39, while patients over 40 plateaued at about 22% after four cycles.⁸ The consistent finding across studies is that IVF can largely overcome infertility in younger women, but it does not reverse the age-related decline in egg quality.⁹ Using donor eggs from a younger person erases that age differential, which is why donor-egg cycles show similar success rates regardless of the recipient’s age.

Genetic Testing Before Transfer

Before an embryo goes back into the uterus, clinics can offer preimplantation genetic testing. A few cells are biopsied from the outer layer of the blastocyst and analyzed. There are three main forms: one screens for abnormal chromosome counts, another tests for specific single-gene disorders like cystic fibrosis or sickle cell disease, and a third looks for structural chromosome rearrangements that a parent is known to carry.¹⁰

One complication that genetic testing has revealed is mosaicism, where some cells in the biopsy show normal chromosomes and others do not. A systematic review and meta-analysis found that mosaic embryos have lower implantation and live-birth rates than chromosomally normal embryos, but once a mosaic embryo does implant, miscarriage rates are comparable, and neonatal health outcomes appear reassuring.¹¹ Not all mosaicism carries equal risk. Embryos with segmental mosaicism (involving only part of a chromosome) tend to have better outcomes than those with whole-chromosome mosaicism, and trisomy mosaics fare particularly poorly compared to other types.¹² This matters because couples who have only mosaic embryos left face a difficult decision about whether to transfer one or start another cycle.

Fresh Versus Frozen Embryo Transfer

Not all embryos are transferred immediately. Freezing embryos and transferring them in a later cycle has become common practice, and the two approaches produce subtly different birth outcomes. A large Finnish cohort found that babies born from frozen transfers tended to weigh more and were less likely to be born small for gestational age compared to babies from fresh transfers.¹³ A Catalan study of over 14,000 newborns confirmed that in the autologous-egg population, fresh-transfer babies weighed less and had a higher risk of being small for gestational age.¹⁴

A Norwegian within-sibling study added nuance by comparing IVF children to their naturally conceived siblings in the same families. Fresh-transfer singletons were born about a day earlier and weighed about 50 grams less than their naturally conceived siblings, while frozen-transfer singletons weighed about 80 grams more. Frozen-transfer babies also had nearly double the odds of being large for gestational age. The increased risk of very preterm birth seen in population-level analyses largely disappeared in the sibling comparison, suggesting that some of the apparent risk comes from parental characteristics rather than the IVF procedure itself.¹⁵

Long-Term Health of IVF-Conceived Children

The oldest IVF-conceived person is now in her late forties, so long-term health data is still accumulating. A systematic review and meta-analysis of cardiovascular and metabolic profiles found that IVF/ICSI offspring had blood pressure levels that were statistically higher than naturally conceived peers, roughly two points higher for systolic pressure. Their cardiac function showed subtle differences, and vessel walls were slightly thicker. Body weight and cholesterol were comparable, but fasting insulin levels were higher.¹⁶ A separate study of Chinese children echoed these findings, reporting higher fasting blood glucose, insulin levels, and insulin resistance in the IVF group, along with elevated arterial wall thickness on ultrasound.¹⁷

These differences are small in absolute terms and have not translated into obvious disease in childhood. But they raise questions about what happens as these individuals age into their fifties and sixties. The honest answer is that nobody knows yet. Researchers are tracking large cohorts to find out.

Epigenetic Concerns

One area that generates both scientific interest and parental anxiety is epigenetics, particularly imprinting disorders. These are rare conditions caused by abnormal activation or silencing of certain genes, and some evidence suggests IVF may increase the risk. A meta-analysis found that children conceived through IVF/ICSI had roughly three to four times the odds of an imprinting disorder compared to naturally conceived children.¹⁸ A Swedish population-based study found a similar elevation, with an adjusted hazard ratio of about 1.5 for any imprinting disorder. The risk was particularly pronounced when ICSI was combined with frozen embryo transfer, where certain imprinting disorders were four to nearly seven times more common.¹⁹

These relative increases sound alarming, but context matters. Imprinting disorders like Beckwith-Wiedemann syndrome and Angelman syndrome are extremely rare in the general population, occurring in roughly one in ten to fifteen thousand births. Even with a several-fold increase, the absolute risk to any individual IVF child remains very low.²⁰ It remains unclear whether the elevated risk comes from the IVF procedures themselves, from the underlying infertility, or from a combination of both. Animal studies support a biological connection between lab culture conditions and epigenetic changes, so the concern is plausible even if the absolute numbers are reassuring.

Risks for the Person Undergoing Treatment

The physical demands of IVF fall overwhelmingly on the person providing the eggs. The most significant medical risk during ovarian stimulation is ovarian hyperstimulation syndrome, a condition in which the ovaries swell dramatically and fluid leaks from blood vessels into the abdomen and sometimes around the lungs. In its mild form, OHSS causes bloating and discomfort. In severe cases, it can lead to blood clots, kidney problems, and hospitalization.²¹ The syndrome is triggered by human chorionic gonadotropin, the hormone used to induce final egg maturation, and is more common in younger patients and those with polycystic ovary syndrome.²²

Modern prevention strategies have substantially reduced severe cases. Switching to GnRH antagonist protocols, using a GnRH agonist trigger instead of hCG, performing in vitro maturation of eggs, and freezing all embryos to delay transfer have all helped lower the incidence.²³ But OHSS has not been eliminated entirely, and clinics vary in how aggressively they prevent it.

The Emotional and Financial Weight

IVF is not just physically taxing. Both women and men undergoing treatment experience elevated levels of anxiety and depression, though women consistently report higher psychological distress at nearly every stage of the process.²⁴ One US study found that pursuing IVF was the only factor independently associated with fertility-related stress, even after adjusting for demographics and the total time spent on care.²⁵

The financial barrier is equally significant. Economic research has shown that the rate of IVF use drops by half when insurance does not cover treatment.²⁶ That same analysis estimated couples are willing to pay at most about a third of their annual disposable income for a cycle that gives roughly a 40% chance of having a child. The financial sensitivity is even sharper at lower incomes, meaning IVF access is deeply unequal. In countries without public funding or insurance mandates, IVF remains effectively available only to those who can afford it.

Add-Ons That Clinics Offer

IVF clinics frequently offer supplementary procedures marketed as boosting success rates. A large review of these so-called “add-ons” found that the evidence supporting nearly all of them is thin. Of the add-ons evaluated for live-birth outcomes, endometrial scratching showed a small possible benefit. Four others, including EmbryoGlue, preimplantation genetic testing for aneuploidy, endometrial receptivity testing, and corticosteroids, appeared to have no effect on live-birth rates. Five more, including physiological ICSI, acupuncture, intralipid infusion, and platelet-rich plasma treatments, had evidence that was either too weak or too scarce to draw conclusions.²⁷ The gap between patient demand for these extras and the evidence behind them is substantial.²⁸ If a clinic is recommending something beyond the standard protocol, it is worth asking what the evidence actually shows before paying for it.

AI and Embryo Selection

One of the more promising technological frontiers involves using artificial intelligence to help choose which embryo to transfer. Traditional embryo grading relies on an embryologist visually assessing shape, cell number, and fragmentation, a process that is somewhat subjective and varies between clinics. AI models trained on time-lapse imaging, where cameras inside the incubator photograph each embryo every few minutes, can detect patterns invisible to the human eye. One deep-learning system predicted live birth from time-lapse images of 470 transferred embryos and found that embryos scoring above its threshold had significantly higher live-birth rates.²⁹ Other models have been tested across multiple clinics to assess whether their predictions hold up when patient populations differ, particularly in maternal age distribution.³⁰ The field is still early, and no AI tool has yet proven in large randomized trials that it definitively improves live-birth rates. But the trajectory suggests AI-assisted embryo selection will become standard practice within the next decade.

Third-Party Reproduction and Disclosure

IVF also makes it possible to involve third parties: egg donors, sperm donors, and gestational surrogates. These arrangements expand who can become a parent, including single individuals, same-sex couples, and people with medical conditions that prevent them from producing gametes or carrying a pregnancy. They also raise questions about what to tell the resulting children. A study that interviewed over 100 families when their children were seven found stark differences. Nearly all surrogacy parents had told their child about how they were born. By contrast, about half the egg-donation families and roughly three-quarters of donor-insemination families had not told the child that the person they call their parent was not genetically related to them.³¹ The researchers found that labeling families simply as “secret” or “open” was inadequate; most parents engaged in layered disclosure, sharing information selectively with different people at different times.

The Problem of Leftover Embryos

When stimulation produces many eggs and several good embryos result, the extras are typically frozen. Many couples complete their families with embryos to spare, and the question of what to do with them has no easy answer. Options include donating them to another couple, donating them to research, having them thawed and discarded, or continuing to pay storage fees indefinitely. Some couples cannot bring themselves to choose, and clinics end up storing embryos whose owners have stopped paying and stopped responding to contact attempts.³² The tension between respecting parental autonomy and managing a growing inventory of unclaimed embryos is a practical and ethical challenge that regulations have only partially addressed.

Artificial Gametes and What Comes Next

Looking further ahead, researchers are working on creating eggs and sperm from stem cells, a field called in vitro gametogenesis. In mice, scientists have already produced functional eggs and sperm from stem cells that resulted in live offspring.³³ In humans, the work is much earlier: stem cells have been coaxed into early-stage egg cells and precursors to sperm, but not yet into fully functional gametes. If the technology eventually works, it could allow people who currently have no eggs or sperm of their own, whether because of cancer treatment, genetic conditions, or aging, to have genetically related children without donor gametes.³⁴ It could also, at least theoretically, allow two people of the same sex to both be genetic parents of the same child. These possibilities raise ethical questions that society has barely begun to discuss, though the technical barriers remain formidable enough that clinical use is likely years or decades away. The broader trajectory is clear, though: IVF is not a static technology. Societal demand driven by delayed childbearing, changing family structures, and fertility preservation is growing, and emerging tools from AI embryo grading to stem-cell-derived gametes are set to transform the field further.³⁵